Clinical Trials Logo
  1. Home
  2. Liver Dysfunction
  3. NCT05559242

Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients

Liver Dysfunction Clinical Trial

Official title:
To Evaluate the Phase I Pharmacokinetics of Anlotinib Hydrochloride Capsules in Liver Dysfunction Patients and Healthy Subjects

Clinical Trial Summary

To evaluate the pharmacokinetic difference of anlotinib hydrochloride capsule between mild/moderate liver dysfunction subjects and healthy subjects, and to provide basis for formulating the clinical drug regimen for patients with liver dysfunction.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05559242
Study type Interventional
Source Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact Hong Ren, Master of Medicine
Phone +86 13983888786
Email renhong0531@vip.sina.com.cn
Status Not yet recruiting
Phase Phase 1
Start date October 2022
Completion date July 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT02754219 - Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction Phase 1
Terminated NCT01079104 - Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units N/A
Recruiting NCT00553553 - Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery N/A
Completed NCT03641872 - A Validation Cohort for ACLF Diagnosis and Prognosis
Completed NCT03371537 - Study of Hemodynamic Conditions Measured During Hepatectomy
Recruiting NCT02473601 - Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis Phase 2
Completed NCT01000337 - Markers of Liver Apoptosis After Anesthesia With Sevoflurane or Propofol N/A
Completed NCT03155984 - Optimizing HBV Management During Anti-CD20 Antibodies
Recruiting NCT06126419 - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration N/A
Completed NCT03515980 - An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function Phase 1
Completed NCT01338714 - The Effect of Compound Herbal Formula (RHD-1) on HBV Carrier With Abnormal Liver Function Phase 3
Completed NCT02005744 - A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function Phase 1
Completed NCT01367522 - Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function Phase 1
Recruiting NCT03805139 - Role of Ajwa Derived Polyphenols in Dyslipidaemias N/A
Enrolling by invitation NCT05082077 - Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Completed NCT02949505 - Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation N/A
Completed NCT02991339 - The Effects of Dexamethasone Administration on Jaundice Following Liver Resection Phase 2/Phase 3
Completed NCT02992639 - Weight Loss Effect on Circulating Liver Enzymes N/A
Recruiting NCT05793203 - Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients
Recruiting NCT03519074 - Cisplatin Combined With Oral TS-1 in Patients With Advanced Solid Tumors With Different Degrees of Liver Dysfunction Phase 2